Disc Medicine (IRON) Equity Average (2020 - 2026)

Disc Medicine (IRON) has 7 years of Equity Average data on file, last reported at $714.1 million in Q1 2026.

• Quarterly Equity Average rose 29.38% year-over-year to $714.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $714.1 million (up 29.38% YoY) and the FY2025 annual result came in at $591.7 million, up 50.04% from the prior year.
• Equity Average climbed to $714.1 million in Q1 2026 per IRON's latest filing, from $656.6 million in the prior quarter.
• Across five years, Equity Average topped out at $714.1 million in Q1 2026 and bottomed at -$90.7 million in Q3 2022.
• The 5-year median for Equity Average is $365.1 million (2023), against an average of $345.2 million.
• The widest annual swing landed in 2022, when Equity Average tumbled 196.85%; it then surged 801.84% in 2023.
• Tracing IRON's Equity Average over 5 years: stood at $39.0 million in 2022, then surged by 801.84% to $352.0 million in 2023, then climbed by 29.46% to $455.8 million in 2024, then surged by 44.06% to $656.6 million in 2025, then advanced by 8.76% to $714.1 million in 2026.
• Per Business Quant, the three latest IRON Equity Average figures stand at $714.1 million (Q1 2026), $656.6 million (Q4 2025), and $593.8 million (Q3 2025).

Peer Comparison